Michelle McDonald
Papers
1
Total Citations
52
H-Index
1
About
Michelle McDonald is a leading urologic oncologist whose research centers on optimizing surgical outcomes for kidney cancer patients, with a particular focus on robotic partial nephrectomy techniques. Her most influential work, a 2017 study comparing retroperitoneal and transperitoneal approaches, has garnered 52 citations and established a critical framework for achieving "Pentafecta" outcomes—a composite measure encompassing perioperative safety, renal function preservation, and oncologic control. McDonald’s contributions have directly shaped clinical decision-making by demonstrating that the retroperitoneal approach can reduce operative time and hospital stays without compromising functional results. Her research is widely recognized for its rigorous methodology and practical impact, helping surgeons tailor procedures to individual patient anatomy. Beyond this landmark study, McDonald continues to advance the field through investigations into minimally invasive techniques and long-term renal function outcomes. Her work has been instrumental in refining the standards for nephron-sparing surgery, making her a respected voice in urologic oncology and a valuable resource for trainees and colleagues seeking evidence-based guidance in complex kidney cancer management.
Research Focus
Key Achievements
Top Papers
- 1